Trial intelligence / Profile preview

Avotermin for Scar Prevention in Elderly Subjects

NCT00847795Phase 2Completed

Sponsor
Renovo
Start
Sep 2002
Primary completion
Jun 2003
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of avotermin in cicatrix, sponsored by Renovo. Started Sep 2002; status: completed.

02

Drugs

avotermin
03

Conditions

cicatrix

Beyond the preview

Go deeper on NCT00847795.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00847795.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call